Literature DB >> 25960330

Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.

Noriyasu Kamei1, Yukina Aoyama1, El-Sayed Khafagy2, Mao Henmi1, Mariko Takeda-Morishita3.   

Abstract

Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Caco-2 cells; Cell-penetrating peptide; Insulin; Intermolecular interaction; Oral absorption; Penetratin

Mesh:

Substances:

Year:  2015        PMID: 25960330     DOI: 10.1016/j.ejpb.2015.04.030

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer's disease mouse model.

Authors:  Noriyasu Kamei; Ayaka Hashimoto; Erina Tanaka; Kaho Murata; Maika Yamaguchi; Natsuki Yokoyama; Masahiro Kato; Keisuke Oki; Takashi Saito; Takaomi C Saido; Mariko Takeda-Morishita
Journal:  Drug Deliv Transl Res       Date:  2022-01-11       Impact factor: 5.671

2.  Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.

Authors:  El-Sayed Khafagy; Ruisha Iwamae; Noriyasu Kamei; Mariko Takeda-Morishita
Journal:  AAPS J       Date:  2015-07-28       Impact factor: 4.009

3.  Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.

Authors:  Bader B Alsulays; Md Khalid Anwer; Gamal A Soliman; Sultan M Alshehri; El-Sayed Khafagy
Journal:  Int J Nanomedicine       Date:  2019-11-25

Review 4.  Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos.

Authors:  Mie Kristensen; Ditlev Birch; Hanne Mørck Nielsen
Journal:  Int J Mol Sci       Date:  2016-01-30       Impact factor: 5.923

Review 5.  Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs.

Authors:  Wei Liu; Hao Pan; Caiyun Zhang; Liling Zhao; Ruixia Zhao; Yongtao Zhu; Weisan Pan
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.